Greece has reported 11,124 new cases of COVID-19 in the past 24 hours, bringing the total number of confirmed cases to 1,920,992, the Country’s national Public Health Organization announced on Monday evening. A total of 23,372 people have died, with 97 new deaths reported.

A paper published recently in the Annals of Internal Medicine, a leading international scientific journal, has reportedly mentioned the possibility of re-infection in novel Coronavirus patients. Stavrola Paschu, Dioradora Pasaldobulu and Sanos Dimopoulos, professors at the University of Athens School of Medicine, summed up the main points of the paper.

The scientists involved in the study compared the risk of reinfection after infection with the Novel Coronavirus with the risk of infection in previously uninfected individuals when exposed to the Novel Coronavirus. The results showed that people who recovered after infection had an 80 to 98 percent lower risk of contracting the primary or alpha-variant of the virus compared to people who had not been vaccinated and had never been infected.

People who were previously infected had an 87 percent lower risk of reinfection, according to an analysis of the data. Meanwhile, infected people can maintain an 80% response rate to antibodies for seven months.

The results of the study did not cover patients infected with Delta or Omicron, and the scientists said further studies would be carried out on the efficacy and validity of antibodies in patients infected with the mutated strain.